77.88 USD
↘ 1.93 (2.42%)AT CLOSE (03:59 PM EST)
CareDx, Inc.
CDNANASDAQ • USD
78.26
↗ 0.38 (0.49%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
78.26
↗ 0.38 (0.49%)
Market: CLOSED
CareDx, Inc. (CDNA) is currently trading at $77.88. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (27.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.
Open?$78.51
High?$80.00
Low?$76.66
Prev. Close?$79.81
Volume?717.0K
Avg. Volume?1.4M
VWAP?$78.10
Rel. Volume?0.52x
Bid / Ask
Bid?$76.70 × 100
Ask?$79.42 × 200
Spread?$2.72
Midpoint?$78.06
Valuation & Ratios
Market Cap?4.1B
Shares Out?52.5M
Float?50.2M
Float %?97.0%
P/E Ratio?31.81
P/B Ratio?8.75
EPS?$2.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Themes
Employees
765
Market Cap
4.2B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2014-07-17
Address
8000 MARINA BLVD
BRISBANE, CA 94005
Phone: 415-287-2300
BRISBANE, CA 94005
Phone: 415-287-2300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?73
Short Sent.?55
Piotroski F-Score?4/9Mixed
Altman Z-Score?24.12Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?14.32%High
Short Interest?7.2M
Days to Cover?5.3
Free Float50.2M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.31Strong
Quick Ratio?2.25Strong
Cash Ratio?1.80Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?31.8PRICEY▾
Peers100
S&P29
P/B?8.75HIGH▾
Peers100
S&P21
P/S?8.23HIGH▾
Peers100
S&P12
P/FCF?68.5PRICEY▾
Peers100
S&P5
EV/EBITDA?175.2HIGH▾
Peers100
S&P3
EV/Sales?7.72HIGH▾
Peers100
S&P18
Returns & Efficiency
ROE?27.5%STRONG▾
Peers50
S&P77
ROA?20.1%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$59.8M
Enterprise Value?$3.8B
Fundamentals ratios updated end of day